A 14-year-old girl with metastatic renal cell carcinoma was treated with nephrectomy, interferon, and several lines of the targeted agents sorafenib, bevacizumab, sunitinib, and everolimus, either alone or in combination. Treatment was well tolerated, but the patient developed hypothyroidism and significant hypertension with bevacizumab and sunitinib. She responded to all agents and was given radiation treatment twice at the time of symptomatic disease progression; she died 33 months from diagnosis.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Continuing Response to Subsequent Treatment Lines With Tyrosine Kinase Inhibitors in an Adolescent With Metastatic Renal Cell Carcinoma|
|Data di pubblicazione:||2011|
|Appartiene alla tipologia:||01a Articolo in rivista|